. Author manuscript; available in PMC: 2013 Apr 25.

Published in final edited form as: J Nucl Med. 2012 Mar 1;53(4):567–574. doi: 10.2967/jnumed.111.094425

Table 1. Distribution of Background-Corrected SUV_max, Percentage Change in SUV_max, and GLUT4 Fold Decrease.

Measurement	Timing	Category	Number of participants	Number missing	Minimum	Median	Mean	Maximum	P
Background-corrected SUV_max
	Baseline		44	0	1.3	10.1	14.2	53.2
	Week 1		44	0	−0.5	2.7	5.5	47.7	<0.0001^*
	Presurgery		40	4	−0.5	1.4	3.0	36.1	<0.0001^*
Change in SUV_max from baseline (%)
	Week 1		44	0	−100.0	−72.0	−59.4	81.4	<0.0001^†
	Presurgery		40	4	−100.0	−89.6	−76.4	13.4	<0.0001^†
GLUT4 fold decrease
	Week 1	CMR	1	2	4.3	4.3	4.3	4.3
		PMR	17	16	1.0	2.3	9.1	100.0
		SMD	3	3	1.0	2.0	2.5	4.5
		PMD	1	1	1.7	1.7	1.7	1.7
	Presurgery	CMR	1	2	3.0	3.0	3.0	3.0
		PMR	19	14	1.0	2.1	8.4	100.0
		SMD	2	2	1.7	3.1	3.1	4.5
		PMD	0	0

Wilcoxon signed-rank test comparing week 1 (presurgery) absolute SUVmax against baseline.

^†

Wilcoxon signed-rank test comparing week 1 (presurgery) percentage change in SUVmax from baseline.

Table 1. Distribution of Background-Corrected SUVmax, Percentage Change in SUVmax, and GLUT4 Fold Decrease.